Fayet B, Racy E, Ruban J-M, Katowitz J
Department of Ophthalmology, Hôtel-Dieu de Paris, University of Paris VI - Medical School, 1, place du Parvis-Notre-Dame, 75181 Paris cedex 04, France.
J Fr Ophtalmol. 2011 Nov;34(9):597-607. doi: 10.1016/j.jfo.2011.02.008. Epub 2011 Jun 1.
To present our experience with pushed monocanalicular nasolacrimal intubation in the management of 90 consecutive cases of nasolacrimal outflow obstruction.
This paper reports a non-randomized study of 90 consecutive cases treated with a pushed Monoka intubation system (Masterka™). A metal guide is placed inside a silicone tube rather than being attached at the distal end of the tube, as done with traditional pulled intubations. Three probe lengths are available: 30, 35, and 40 mm.
The silicone stent was pushed into a punctum, canaliculus, and nasolacrimal duct by means of the guide. After passing through the valve of Hasner and reaching the nasal floor, the guide was then delicately withdrawn while remaining oriented along the axis of the lacrimal sac and duct. Throughout this phase, the anchoring plug was held in contact with the punctum. Three study groups were set up chronologically: group 1: endo-DCR procedures done with Masterka insertions under endoscopic observation. Group 2: Masterka insertions done with endoscopic guidance. Group 3: blind Masterka insertions without endoscopic guidance. The patients in groups 2 and 3 were selected on the information obtained by lacrimal probing. Only cases with mucosal nasolacrimal stenoses were included. All patients had surgery under general anesthesia with mechanically assisted ventilation (groups 1 and 2) or spontaneous ventilation (group 3). The anchoring plug was inserted into the punctum and vertical canaliculus, either by pulling on the probe (group 1) or using an inserting instrument.
A total of 90 pushed Monoka intubations were done. Endoscopic examination (groups 1 and 2) demonstrated visually that the pushed intubation method was effective. In none of the 28 cases did the silicone bunch up when the guide was withdrawn. DEGREE OF DIFFICULTY: This was dependent upon proper selection for pushed Monoka intubation; the length of the probe and confirmation that there no false passage was created. The pushed intubation technique was only slightly more difficult than a simple lacrimal probing. The average operating time, excluding the anesthetic procedures, was respectively 5 min (group 2) and 4 min (group 3). COMPLICATIONS DURING SURGERY: There were no anesthetic or general problems observed in the three groups. Epistaxis was also not noted.
Fifteen percent (13/90). The 13 complications noted were: two cases of canaliculitis, one intracanalicular migration, eight probes that disappeared, one keratitis, and one case of involuntary removal by the patient. DELETERIOUS SIDE EFFECTS: Tearing with the probe was in place was noted in 21.1% of the cases (19/90). This tearing disappeared as soon as the probe was removed in 50% of these cases (10/19).
Overall, the success rate (absence of epiphora, absence of mucous discharge) was 90% (81/90) with an average follow-up period of 19 weeks (Range, 1 day to 60 weeks). Two cases were lost to follow-up at day 1 and day 7. Group 1: 90.9% (20/22 cases; average age: 65 years, with an average follow-up period of 24 weeks). Group 2: 100% (6/6 cases; average age: 3.1 years, with an average follow-up period of 14 weeks). Group 3: 88.3% (53/60 cases excluding the two cases that were lost to follow-up; mean age: 2.3 years, with an average follow-up period of 16 weeks).
From a technical perspective, pushed nasolacrimal intubation is much simpler than the traditional pulled types of nasolacrimal intubation. The anesthetic procedure required is the same as that for a late probing procedure, but the functional results are better. The Masterka is an alternative to simple late probing in the treatment of mucosal nasolacrimal stenoses in patients of over 12 months of age.
介绍我们在连续90例鼻泪管阻塞治疗中采用推送式单泪小管鼻腔泪囊插管术的经验。
本文报道一项对连续90例患者采用推送式Monoka插管系统(Masterka™)进行的非随机研究。金属导丝置于硅胶管内,而非像传统牵拉式插管那样附于管的远端。有三种探头长度可供选择:30、35和40毫米。
通过导丝将硅胶支架推送至泪点、泪小管和鼻泪管。穿过哈氏瓣膜并到达鼻底后,沿泪囊和泪管轴线方向小心抽出导丝,在此过程中,固定塞始终与泪点接触。按时间顺序设立三个研究组:第1组:在内镜观察下使用Masterka插管进行鼻内镜下泪囊鼻腔造口术(endo-DCR)。第2组:在内镜引导下进行Masterka插管。第3组:无内镜引导下盲目进行Masterka插管。第2组和第3组患者根据泪道探通获得的信息选取,仅纳入黏膜性鼻泪管狭窄病例。所有患者均在全身麻醉下手术,第1组和第2组采用机械辅助通气,第3组采用自主通气。通过牵拉探头(第1组)或使用插入器械将固定塞插入泪点和垂直泪小管。
共进行了90次推送式Monoka插管。内镜检查(第1组和第2组)直观显示推送式插管方法有效。在28例中,抽出导丝时硅胶均未出现卷曲。
这取决于对推送式Monoka插管的正确选择、探头长度以及确认未形成假道。推送式插管技术仅比简单的泪道探通稍难。排除麻醉程序后的平均手术时间,第2组为5分钟,第3组为4分钟。
三组均未观察到麻醉或全身问题,也未出现鼻出血。
15%(13/90)。记录的13例并发症为:2例泪小管炎、1例管内移位、8根探头消失、1例角膜炎和1例患者自行拔除。
21.1%的病例(19/90)在探头在位时有流泪现象,其中50%(10/19)的病例在探头拔除后流泪立即消失。
总体而言,成功率(无溢泪、无黏液分泌物)为90%(81/90),平均随访期为19周(范围1天至60周)。第1天和第7天有2例失访。第1组:90.9%(20/22例;平均年龄65岁,平均随访期24周)。第2组:100%(6/6例;平均年龄3.1岁,平均随访期14周)。第3组:88.3%(60例中排除2例失访病例后为53/60例;平均年龄2.3岁,平均随访期16周)。
从技术角度看,推送式鼻泪管插管比传统牵拉式鼻泪管插管简单得多。所需麻醉程序与晚期探通术相同,但功能结果更好。Masterka是12个月以上患者黏膜性鼻泪管狭窄治疗中简单晚期探通术的一种替代方法。